Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
BACKGROUND
Early diagnosis of pulmonary hypertension (PH) in idiopathic pulmonary fibrosis (IPF) has potential prognostic and therapeutic implications but can be difficult due to the lack of specific clinical manifestations or accurate non-invasive tests. Histopathologic parameters correlating with PH in IPF are also not known. Remodeling of postcapillary pulmonary vessels has been reported in the nonfibrotic areas of explanted lungs from IPF patients. We hypothesized that iron deposition and increased alveolar capillaries, the findings often seen in postcapillary PH, might predict the presence of clinical PH, independent of the severity of fibrosis or ventilatory dysfunction in IPF patients. To test this hypothesis, we examined the association between these histologic parameters and the degree of PH, with consideration of the severity of disease in IPF.


METHODS
Iron deposition and alveolar septal capillary density (ASCD) were evaluated on histologic sections with hematoxylin-eosin, iron, elastin and CD34 stainings. Percentage of predicted forced vital capacity (FVC%) was used for grading pulmonary function status. Fibrosis score assessed on high resolution computed tomography (HRCT) was used for evaluating overall degree of fibrosis in whole lungs. Right ventricular systolic pressure (RVSP) by transthoracic echocardiography was used for the estimation of PH. Univariate and multivariate regression analyses were performed.


RESULTS
A cohort of 154 patients was studied who had the clinicopathological diagnosis of IPF with surgical lung biopsies or explants during the period of 1997 to 2006 at Mayo Clinic Rochester. In univariate analysis, RVSP in our IPF cases was associated with both iron deposition and ASCD (p < 0.001). In multivariate analysis with FVC% and HRCT fibrosis score included, iron deposition (p = 0.02), but not ASCD (p = 0.076), maintained statistically significant association with RVSP. FVC% was associated with RVSP on univariate analysis but not on multivariate analysis, while fibrosis score lacked any association with RVSP by either univariate or multivariate analyses.


CONCLUSIONS
Iron deposition and ASCD in non fibrotic lung tissue showed an association with RVSP, suggesting that these features are possible morphologic predictors of PH in IPF.
Kim
Kyung-Hee
KH
Department of Laboratory Medicine and Pathology, division of Anatomic Pathology Mayo Clinic, Rochester, Minnesota, USA. phone330@cnu.ac.kr
Maldonado
Fabien
F
Ryu
Jay H
JH
Eiken
Patrick W
PW
Hartman
Thomas E
TE
Bartholmai
Brian J
BJ
Decker
Paul A
PA
Yi
Eunhee S
ES
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D002196:Capillaries / Q000473:pathology; D015150:Echocardiography, Doppler; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D054990:Idiopathic Pulmonary Fibrosis / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D007501:Iron / Q000378:metabolism*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011650:Pulmonary Alveoli / Q000098:blood supply* / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D014057:Tomography, X-Ray Computed; D016278:Ventricular Function, Right; D017725:Ventricular Pressure; D014797:Vital Capacity
D007501:Iron
Am J Respir Crit Care Med. 2001 Oct 1;164(7):1171-81
11673205
Am J Respir Crit Care Med. 2007 May 1;175(9):875-80
17255562
Chest. 2007 Sep;132(3):998-1006
17873194
J Clin Invest. 2007 Mar;117(3):549-56
17332882
Am J Respir Crit Care Med. 2003 Sep 1;168(5):531-7
12791580
Am Rev Respir Dis. 1981 Jun;123(6):659-64
7271065
Am J Respir Crit Care Med. 2003 Feb 1;167(3):438-43
12406847
Am J Clin Pathol. 2000 May;113(5):655-62
10800397
Hum Pathol. 2007 Jan;38(1):60-5
16949908
Chest. 2007 Mar;131(3):874-879
17356107
Am J Physiol Lung Cell Mol Physiol. 2000 Aug;279(2):L371-8
10926561
Am J Respir Crit Care Med. 2004 Jun 1;169(11):1203-8
14754760
Eur Radiol. 2007 Apr;17(4):911-8
16941093
Thorax. 1963 Sep;18:225-37
14064617
Chest. 2006 Mar;129(3):746-52
16537877
Chest. 2007 Mar;131(3):657-663
17356077
Am J Forensic Med Pathol. 2000 Dec;21(4):319-22
11111789
Am J Respir Crit Care Med. 2004 Aug 1;170(3):242-51
15117744
Am J Surg Pathol. 2000 Jan;24(1):19-33
10632484
Eur Respir J. 2008 Jun;31(6):1357-67
18515559
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
11790668
Am J Respir Crit Care Med. 2004 Aug 1;170(3):207-9
15280169
Chest. 2005 Oct;128(4):2393-9
16236900
Hum Immunol. 2006 Apr-May;67(4-5):284-97
16720208
Chest. 2007 Sep;132(3):773-9
17573485
Am J Respir Crit Care Med. 2003 Mar 1;167(5):735-40
12480614
Am J Transplant. 2006 Feb;6(2):398-403
16426327
J Immunol. 1997 Aug 1;159(3):1437-43
9233641
Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1301-15
9563754